REGENXBIO
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell REGENXBIO and other ETFs, options, and stocks.About RGNX
REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381.
CEOCurran M. Simpson
CEOCurran M. Simpson
Employees353
Employees353
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2008
Founded2008
Employees353
Employees353
RGNX Key Statistics
Market cap656.83M
Market cap656.83M
Price-Earnings ratio-3.72
Price-Earnings ratio-3.72
Dividend yield—
Dividend yield—
Average volume705.95K
Average volume705.95K
High today$13.77
High today$13.77
Low today$12.82
Low today$12.82
Open price$12.82
Open price$12.82
Volume908.09K
Volume908.09K
52 Week high$13.93
52 Week high$13.93
52 Week low$5.04
52 Week low$5.04
Stock Snapshot
As of today, REGENXBIO(RGNX) shares are valued at $12.98. The company's market cap stands at 656.83M, with a P/E ratio of -3.72.
During the trading session on 2025-12-04, REGENXBIO(RGNX) shares reached a daily high of $13.77 and a low of $12.82. At a current price of $12.98, the stock is +1.2% higher than the low and still -5.7% under the high.
Trading volume for REGENXBIO(RGNX) stock has reached 908.09K, versus its average volume of 705.95K.
The stock's 52-week range extends from a low of $5.04 to a high of $13.93.
The stock's 52-week range extends from a low of $5.04 to a high of $13.93.
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own RGNX. This list is generated using Robinhood data, and it’s not a recommendation.